Healogics Executive and Leadership Team

Jim Henry, the Chief Executive Officer at Healogics, directs the overarching corporate strategy and operational execution. Overseeing all business units, Henry ensures alignment with the company's mission to provide advanced wound care services. This leadership role involves driving growth initiatives and optimizing resource allocation across the organization. By focusing on market expansion and service delivery excellence, Jim Henry directly impacts the company's ability to serve patients with chronic wounds, including diabetic ulcers, surgical wounds, and venous ulcers. Henry's strategic vision guides the enterprise in maintaining its position as a leader in specialized wound treatment.

Pamela Mandel, the Chairman & Chief Executive Officer at Healogics, provides executive leadership and strategic direction for the organization. Mandel's responsibilities encompass guiding the company's long-term vision and ensuring robust governance. This executive role involves fostering a culture of innovation and excellence in advanced wound care services. By championing initiatives that enhance patient outcomes for chronic wounds, Pamela Mandel significantly contributes to the company's market leadership. Mandel's oversight extends to critical business decisions that shape the future of Healogics' operations and its impact on treating conditions like pressure ulcers and arterial ulcers.

Gregory Martin, the Chief Operating Officer at Healogics, directs the day-to-day operational activities and service delivery across the organization. Martin's focus is on optimizing the efficiency and effectiveness of wound care centers, ensuring high standards of patient treatment for chronic wounds. This executive position involves managing operational workflows, resource deployment, and performance metrics to enhance patient outcomes. By overseeing the operational execution of strategies for treating conditions like surgical wounds and pressure ulcers, Gregory Martin plays a vital part in the company's success. Martin's leadership ensures seamless service provision and drives continuous improvement in the delivery of advanced wound care.

John Purks, the President, Business Development at Healogics, spearheads strategic growth initiatives and partnership development. Purks is responsible for identifying and securing new opportunities to expand the reach of advanced wound care services. This leadership position involves cultivating relationships with healthcare providers and organizations to enhance patient access to specialized treatment for chronic wounds. By driving market penetration and forging key alliances, John Purks directly contributes to the company's expansion efforts. Purks's focus on business development ensures that Healogics continues to grow its network and serve a broader patient population facing conditions like venous ulcers and surgical wounds.

Mike Wingert, the Division President, Client Solutions at Healogics, leads the strategic engagement and service delivery for the company's client base. Wingert focuses on ensuring that clients receive optimal value and support for their advanced wound care programs. This executive role involves managing client relationships, understanding their unique needs, and tailoring solutions to enhance patient outcomes for chronic wounds. By driving client satisfaction and fostering strong partnerships, Mike Wingert directly impacts the retention and growth of the company's service offerings. Wingert's expertise ensures that Healogics effectively supports its partners in treating conditions such as pressure ulcers and diabetic ulcers.

Mark Gloth, the President & Chief Medical Officer & Head Hsp & of Development Physician at Healogics, provides comprehensive clinical and strategic leadership. Gloth oversees the development of physician services and ensures the highest standards of medical practice in advanced wound care. This multifaceted role involves guiding clinical innovation and physician engagement to improve patient outcomes for chronic wounds. By directing physician development and championing best practices, Mark Gloth significantly enhances the quality of care delivered across Healogics' network. Gloth's leadership ensures that the company's medical strategy effectively addresses complex conditions like arterial ulcers and trauma wounds, reinforcing its commitment to excellence in wound healing.

Emma Spight, the Chief Information Officer at Healogics, architects and executes the company's technology strategy. Spight oversees all aspects of information systems, ensuring robust data security and efficient digital operations to support advanced wound care services. This critical role involves driving technological innovation to enhance patient care delivery and streamline administrative processes for treating chronic wounds. By implementing cutting-edge IT solutions, Emma Spight directly supports the organization's mission to effectively manage conditions such as diabetic ulcers and venous ulcers. Spight's leadership ensures that Healogics leverages technology to maintain its competitive edge and improve operational efficiency across all service lines.

William Ennis, the Chief Medical Officer at Healogics, provides critical clinical leadership and medical oversight for the company's advanced wound care services. Ennis guides the development and implementation of evidence-based treatment protocols for patients with chronic wounds, ensuring the highest quality of care. This senior medical role involves collaborating with clinical teams to address complex cases, including diabetic ulcers, arterial ulcers, and trauma wounds. By championing clinical excellence and innovation, William Ennis directly influences patient outcomes and the overall medical strategy of Healogics. Ennis's expertise ensures that the company remains at the forefront of medical advancements in wound healing.